Most Recent
Condom maker Ansell settles SKYN trade mark spat
Intellectual Property 2019-07-17 1:37 pm By Amelia Birnie

Ansell has settled a dispute with a Perth cosmetic clinic over its proposed registration of the trade mark ‘SKYN Love The Skyn You’re In’, after the Australian rubber latex manufacturer argued it was substantially identical to four of its condom trade marks.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Claims of stolen docs at heart of new suit against Pfizer over vaccine patent
Intellectual Property 2019-07-16 9:48 pm By Miklos Bolza

Merck Sharp & Dohme has claimed ownership of a Pfizer patent related to the blockbuster Prevnar 13 vaccine, after a doctor who moved between the pharmaceutical companies and is listed as an author on the patent allegedly accessed confidential Merck documents before jumping ship to Pfizer.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Subpoena not a ‘garden party invitation’: judge in pelvic mesh class action warns doctor groups
Class Actions 2019-07-16 8:05 pm By Amelia Birnie

A judge overseeing the pelvic mesh class action against Johnson & Johnson subsidiary Ethicon has questioned why three doctor’s professional bodies tried to negotiate court orders requiring them to hand over their member lists, agreeing the supboena was “not a garden party invitation”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Merck Sharp & Dohme loses key battle in trade mark case ahead of trial
Intellectual Property 2019-07-15 8:51 pm By Miklos Bolza

A court has barred US drug company Merck Sharp & Dohme from denying that an agreement made with German pharmaceutical company Merck KGaA was governed by German law, settling a key question before a trade mark case between the two drug giants goes to trial.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Allergan faces potential class action over breast implants linked to rare cancer
Personal injury 2019-07-12 10:07 pm By Christine Caulfield

Slater & Gordon is probing a possible class action against Allergan Australia on behalf of women who developed a rare form of lymphoma linked to the company’s textured breast implants.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

NSW Health to face underpayment class action by junior medical officers
Employment 2019-07-11 2:23 pm By Miklos Bolza

NSW Health is facing a potential class action alleging it underpaid junior medical officers who were denied wages for unscheduled or non-rostered hours worked.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Bayer hit with class action over contraceptive implants
Class Actions 2019-07-09 4:11 pm By Miklos Bolza

Slater & Gordon has filed a class action against life sciences giant Bayer over allegedly defective contraceptive implants that caused serious side effects, requiring many patients fitted with the devices to have hysterectomies.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Ex-Sirtex CEO pleads guilty to insider trading
White Collar 2019-07-03 3:25 pm By Amelia Birnie

The former CEO and director of biotech company Sirtex Medical, Gilman Wong, is facing a maximum ten years in prison after pleading guilty to insider trading.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Country Care slams prosecutors for ‘argumentative’, ‘vague’ criminal cartel case
Competition & Consumer Protection 2019-07-02 9:08 pm By Miklos Bolza

Country Care Group has criticised the DPP for the “argumentative” tone of the notice setting out its criminal cartel case against the mobility equipment provider, and has secured an order for further clarity from prosecutors.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Novartis wants to amend invalidated patent for MS drug
Intellectual Property 2019-07-02 1:30 pm By Amelia Birnie

Novartis has applied to amend its proposed patent for an oral form of multiple sclerosis drug Gilenya, as it appeals an invalidity ruling by IP Australia for lack of inventive step.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?